EXAS
Exact Sciences Corporation · Healthcare · Medical - Diagnostics & Research
Momentum-inputs (vergelijkbare managers):
breedte van houders -11.1% ·
aandelenstroom -1.9% ·
netto nieuwe posities -12.5%
— formule
Brede distributie — dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q1 2026 | 1 | -143 | 11.48K | $1.20M | — | −144 |
| Q4 2025 | 146 | +2 | 107.45M | $10.91B | +5 | −2 |
| Q3 2025 | 23 | +1 | 95.08M | $5.20B | +1 | −1 |
| Q2 2025 | 20 | 0 | 105.61M | $5.61B | — | — |
| Q1 2025 | 17 | -2 | 51.51M | $2.23B | +1 | −3 |
| Q4 2024 | 19 | +2 | 51.81M | $2.91B | +3 | −1 |
| Q3 2024 | 16 | -2 | 41.47M | $2.82B | — | −2 |
| Q2 2024 | 18 | — | 42.26M | $1.79B | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 15.84M | -4.0% | $1.08B | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 2 | Wellington Management ✦ | 14.33M | -3.1% | $976.31M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 14.33M | -3.1% | $976.31M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 14.33M | -3.1% | $976.31M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 14.33M | -3.1% | $976.31M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 14.33M | -3.1% | $976.31M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 14.33M | -3.1% | $976.31M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 14.33M | -3.1% | $976.31M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 3.30M | +178.3% | $224.67M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 3.30M | +178.3% | $224.67M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Geode Capital Management ✦ (passief) | 3.11M | +0.2% | $211.10M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Geode Capital Management ✦ (passief) | 3.11M | +0.2% | $211.10M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Millennium Management ✦ | 1.24M | +83.6% | $84.39M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 14 | Baillie Gifford ✦ | 1.21M | -15.2% | $82.39M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 15 | Baillie Gifford ✦ | 1.21M | -15.2% | $82.39M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 16 | Baillie Gifford ✦ | 1.21M | -15.2% | $82.39M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 17 | Baillie Gifford ✦ | 1.21M | -15.2% | $82.39M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 18 | Norges Bank ✦ (passief) | 680.78K | -45.2% | $46.37M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | PRIMECAP Management ✦ | 496.30K | 0.0% | $33.81M | 0.0% | Held | 2 | SEC ↗ |
| 20 | Soros Fund Management ✦ | 378.59K | +68.3% | $25.79M | 0.7% | ▲ Add | 2 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 254.66K | +65.8% | $16.95M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 254.66K | +65.8% | $16.95M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 254.66K | +65.8% | $16.95M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 254.66K | +65.8% | $16.95M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 25 | ARK Investment Management ✦ | 227.44K | -34.0% | $15.49M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 26 | Gotham Asset Management ✦ | 162.42K | +23.5% | $11.06M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 27 | Fisher Asset Management ✦ | 122.90K | -22.8% | $8.37M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 28 | Renaissance Technologies ✦ | 64.60K | -87.3% | $4.40M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 29 | D. E. Shaw & Co. ✦ | 42.71K | +6.1% | $2.91M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 30 | D. E. Shaw & Co. ✦ | 42.71K | +6.1% | $2.91M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 31 | Citadel Advisors ✦ | 10.73K | -97.7% | $730,859 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Glenview Capital | $26.59M | was 0.6% |
| Point72 Asset Management | $8.27M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 9 houders, 64.35K aandelen, $4.50M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.